Lexington, Mass., Oct. 01, 2021 (GLOBE NEWSWIRE) – FUJIFILM Medical Systems USA, Inc. and FUJIFILM Healthcare Americas Corporation (formerly Hitachi Healthcare Americas) today announced that the two companies have merged and operate as FUJIFILM Healthcare Society of the Americas. The new combined organization brings together the strengths of each company’s innovative product portfolios and talented employees to create new value for customers and advance healthcare.
Leading the combined organization is Henri izawa, President and CEO of FUJIFILM Healthcare Americas Corporation. “We have built a new base by leveraging the strengths of each organization to demonstrate the clinical value and relevance of our combined portfolio,” says Henry Izawa. “The integration of two of Fujifilm’s key healthcare businesses enhances our ability to become an even more comprehensive healthcare partner for our customers. “
Henry Izawa announced the creation of a new management team of FUJIFILM Healthcare Americas Corporation, comprised of seasoned executives from the two legacy companies, to foster a smooth integration and business success.
- June Higuchi is president.
- John hahn is Senior Vice President of Modality Solutions.
- Bill Lacy is Senior Vice President of Medical Informatics.
- Jason heim is Senior Vice President of Sales.
- Randy Vader is Senior Vice President of Regulatory Affairs and Quality.
- Taisuke Fujita is vice president of endoscopy.
- Takehiro Fujimoto is Vice-President of the Office of the President and Chief Executive Officer.
Fujifilm’s comprehensive product portfolio includes solutions for digital radiography, computed tomography, endoscopy, endosurgery, corporate imaging, in vitro diagnostics, magnetic resonance imaging, mammography and ultrasound. In addition, the company is innovating in artificial intelligence (AI) solutions as part of its AI initiative, REiLI®. REiLI brings AI insights directly into the workflows of healthcare professionals, and other REiLI applications will be showcased at this year’s Fujifilm booth at the Radiological Society of North America (RSNA) conference booth # 1911.
“It is an exciting time to be a part of Fujifilm – we are very proud of our comprehensive portfolio of healthcare solutions and our teams who have helped make this integration a success,” said Henry Izawa. “We look forward to leveraging the strengths of each company and product portfolio while remaining committed to our continued growth, expansion and improvement of patient care in a rapidly changing healthcare market. ”
Learn more about Fujifilm healthcare solutions by visiting the company’s virtual hospital here.
FUJIFILM Healthcare Americas Corporation is a leading innovator in enterprise diagnostic and imaging solutions designed to meet the evolving needs of healthcare for prevention, diagnosis and treatment. Fujifilm’s medical imaging portfolio includes solutions for digital radiography, mammography, computed tomography, magnetic resonance imaging, ultrasound, endoscopy and endosurgery. The Synapse® Enterprise Imaging portfolio provides healthcare professionals with the imaging and data access needed to deliver a complete patient record. Fujifilm’s artificial intelligence initiative REiLI® combines Fujifilm’s rich image processing heritage with cutting-edge AI innovations to inspire a new level of clinical confidence. The in vitro diagnostics portfolio provides the gold standard in molecular immunoassay technology for liver monitoring, advanced clinical diagnostic chemicals for major laboratories nationwide, and diagnostic chemicals for branded products. OEM white. The company is headquartered in Lexington, Massachusetts. For more information, please visit Healthcaresolutions-us.fujifilm.com.
FUJIFILM Holdings Corporation, Tokyo, Japan, brings cutting-edge solutions to a wide range of global industries by leveraging its in-depth knowledge and foundational technologies developed in its relentless pursuit of innovation. Its proprietary core technologies contribute to various fields including healthcare, highly functional materials, document solutions and imaging products. These products and services are based on its broad portfolio of chemical, mechanical, optical, electronic and imaging technologies. For the fiscal year ended March 31, 2021, the company achieved worldwide revenue of $ 21 billion, at an exchange rate of 106 yen to the dollar. Fujifilm is committed to responsible stewardship of the environment and good corporate citizenship. For more information, please visit: www.fujifilmholdings.com.